RXi Pharma's Samcyprone successful in mid-stage wart study; shares ahead 10% [Seeking Alpha]
RXI PHARMACEUTICALS CORP (RXII)
Last rxi pharmaceuticals corp earnings: 11/14 07:10 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.rxipharma.com
Company Research
Source: Seeking Alpha
RXi Pharma's Samcyprone successful in mid-stage wart study; shares ahead 10%Nano cap RXi Pharmaceuticals (RXII+9.8%) is up on triple normal volume on the heels of itsannouncement of positive results from a Phase 2 clinical trial, RXI-SCP-1502, evaluating topical med Samcyprone (diphenylcyclopropenone) for the treatment of common warts. The data were presented at the International Investigative Dermatology Conference in Washington, D.C.At end of the once-weekly 10-week treatment period, more than 70% of warts were reduced in size by more than 50%. Complete wart clearance was 54% and up to 71% for certain wart types (non-plantar).On the safety front, there were no treatment-related serious adverse events nor any dose-limiting toxicities. Most of the adverse events observed were mild skin reactions.The company says the results were achieved without any wart preparation, such as soaking or abrasion, typically done before treatment with salicylic acid, the most common first-line treatment.
Show less
Read more
Impact Snapshot
Event Time:
RXII
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RXII alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RXII alerts
High impacting RXI PHARMACEUTICALS CORP news events
Weekly update
A roundup of the hottest topics